Literature DB >> 24642449

Induction of M2 regulatory macrophages through the β2-adrenergic receptor with protection during endotoxemia and acute lung injury.

Jamison J Grailer1, Mikel D Haggadone, J Vidya Sarma, Firas S Zetoune, Peter A Ward.   

Abstract

The main drivers of acute inflammation are macrophages, which are known to have receptors for catecholamines. Based on their function, macrophages are broadly categorized as having either M1 (proinflammatory) or M2 phenotypes (anti-inflammatory). In this study, we investigated catecholamine-induced alterations in the phenotype of activated macrophages. In the presence of lipopolysaccharide (LPS), mouse peritoneal macrophages acquired an M1 phenotype. However, the copresence of LPS and either epinephrine or norepinephrine resulted in a strong M2 phenotype including high levels of arginase-1 and interleukin-10, and a reduced expression of M1 markers. Furthermore, epinephrine enhanced macrophage phagocytosis and promoted type 2 T-cell responses in vitro, which are known features of M2 macrophages. Analysis of M2 subtype-specific markers indicated that LPS and catecholamine-cotreated macrophages were not alternatively activated but were rather of the regulatory macrophage subtype. Interestingly, catecholamines signaled through the β2-adrenergic receptor but not the canonical cAMP/protein kinase A signaling pathway. Instead, the M2 pathway required an intact phosphoinositol 3-kinase pathway. Blockade of the β2-adrenergic receptor reduced survival and enhanced injury in mouse models of endotoxemia and LPS-induced acute lung injury, respectively. These results demonstrate a role for the β2-adrenergic receptor in promoting the M2 macrophage phenotype.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24642449      PMCID: PMC4159611          DOI: 10.1159/000358524

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  39 in total

Review 1.  Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies.

Authors:  D Franchimont
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

2.  A novel phenotype for an activated macrophage: the type 2 activated macrophage.

Authors:  Charles F Anderson; David M Mosser
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

3.  Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood.

Authors:  T van der Poll; J Jansen; E Endert; H P Sauerwein; S J van Deventer
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

4.  Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists.

Authors:  Stefan Fernandez; Purnima Jose; Margarita G Avdiushko; Alan M Kaplan; Donald A Cohen
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

Review 5.  Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities.

Authors:  K D Kröncke; K Fehsel; V Kolb-Bachofen
Journal:  Biol Chem Hoppe Seyler       Date:  1995-06

6.  Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro.

Authors:  R N Spengler; S W Chensue; D A Giacherio; N Blenk; S L Kunkel
Journal:  J Immunol       Date:  1994-03-15       Impact factor: 5.422

7.  Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor.

Authors:  R A Bond; P Leff; T D Johnson; C A Milano; H A Rockman; T R McMinn; S Apparsundaram; M F Hyek; T P Kenakin; L F Allen
Journal:  Nature       Date:  1995-03-16       Impact factor: 49.962

8.  Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation.

Authors:  M Stein; S Keshav; N Harris; S Gordon
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

9.  In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions.

Authors:  Flora Rey-Giraud; Mathias Hafner; Carola H Ries
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

10.  Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.

Authors:  G Strassmann; V Patil-Koota; F Finkelman; M Fong; T Kambayashi
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  55 in total

1.  C/EBPβ regulates the M2 transcriptome in β-adrenergic-stimulated macrophages.

Authors:  Donald M Lamkin; Shreyesi Srivastava; Karen P Bradshaw; Jenna E Betz; Kevin B Muy; Anna M Wiese; Shelby K Yee; Rebecca M Waggoner; Jesusa M G Arevalo; Alexander J Yoon; Kym F Faull; Erica K Sloan; Steve W Cole
Journal:  Brain Behav Immun       Date:  2019-05-24       Impact factor: 7.217

2.  Blocking Sympathetic Nervous System Reverses Partially Stroke-Induced Immunosuppression but does not Aggravate Functional Outcome After Experimental Stroke in Rats.

Authors:  Qi-Wen Deng; Heng Yang; Fu-Ling Yan; Huan Wang; Fang-Lan Xing; Lei Zuo; Han-Qing Zhang
Journal:  Neurochem Res       Date:  2016-04-08       Impact factor: 3.996

3.  The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion.

Authors:  Didem Ağaç; Leonardo D Estrada; Robert Maples; Lora V Hooper; J David Farrar
Journal:  Brain Behav Immun       Date:  2018-09-05       Impact factor: 7.217

Review 4.  Macrophages under pressure: the role of macrophage polarization in hypertension.

Authors:  Sailesh C Harwani
Journal:  Transl Res       Date:  2017-11-08       Impact factor: 7.012

Review 5.  Molecular pathways linking adipose innervation to insulin action in obesity and diabetes mellitus.

Authors:  Adilson Guilherme; Felipe Henriques; Alexander H Bedard; Michael P Czech
Journal:  Nat Rev Endocrinol       Date:  2019-04       Impact factor: 43.330

6.  β-Adrenergic-stimulated macrophages: Comprehensive localization in the M1-M2 spectrum.

Authors:  Donald M Lamkin; Hsin-Yun Ho; Tiffany H Ong; Carly K Kawanishi; Victoria L Stoffers; Nivedita Ahlawat; Jeffrey C Y Ma; Jesusa M G Arevalo; Steve W Cole; Erica K Sloan
Journal:  Brain Behav Immun       Date:  2016-07-30       Impact factor: 7.217

Review 7.  Noradrenergic Modulation on Dopaminergic Neurons.

Authors:  Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2018-03-23       Impact factor: 3.911

Review 8.  Immunological roulette: Luck or something more? Considering the connections between host and environment in TB.

Authors:  John E Pearl; Mrinal Das; Andrea M Cooper
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

9.  Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice.

Authors:  Kathleen M Kokolus; Ying Zhang; Jeffrey M Sivik; Carla Schmeck; Junjia Zhu; Elizabeth A Repasky; Joseph J Drabick; Todd D Schell
Journal:  Oncoimmunology       Date:  2017-12-21       Impact factor: 8.110

10.  M1 to M2 macrophage polarization in heparin-binding epidermal growth factor-like growth factor therapy for necrotizing enterocolitis.

Authors:  Jia Wei; Gail E Besner
Journal:  J Surg Res       Date:  2015-03-18       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.